HER2 has been, and continues to be, a practice-changing biomarker for guiding treatment decisions in breast cancer. Recently, a treatment option became available for...

The goal of this symposium is to educate about the advances in metastatic breast cancer diagnosis and treatment implications.

This program will illustrate key best practices and new developments for biomarker testing in the care of patients with resectable and metastatic non-small cell lung...

This presentation will highlight the progress in histopathology, image acquisition and image analysis in the field with a special emphasis on high throughput whole...

This program provides an overview of the benefits and challenges of testing for various molecular biomarkers in breast cancer from the perspective of the pathologist.

Join us as we discuss the importance of the collaboration between pathology and medical oncology.

This session will follow a patient’s journey from initial biopsy to a clean bill of health, highlighting how digital pathology and AI products like Paige Breast and...

This comprehensive short course aims to support pathologists with clinical training to better understand FRα biology and scoring of this novel IHC marker for EOC samples.

HER2-low (IHC 1+ or 2+/ISH-) is a newly defined subset of HER2 negative breast cancer, representing 60% of this patient population. With recent clinical advancements,...

In this concluding session, Shabnam Jaffer, MD, PhD, explores challenges and considerations when scoring HER2 by IHC, while Savitri Krishnamurthy, MD and Marilyn Bui,...

Throughout this comprehensive course, presenters will share their own best practice guidance for scoring HER2 – by interpretating and reporting discrete HER2 IHC...

Gain insight into how pathology practice will identify patients with all levels of HER2 expressing breast cancers, reinforcing current HER2 testing and interpretation...

Leica Biosystems is proud to present this complimentary webcast with Dr. Eric Glassy, a renowned speaker on Digital Pathology and Dr. Matthew Hanna, Director of...

This session will give listeners an introduction to the pathology of COVID-19, with an emphasis on the lung, which is the main target of this disease. The relationship...

This session will discuss a selected but diverse group of gynecologic tract cases, highlighting some commonly encountered diagnostic problems and concepts. An emphasis...